Advertisement
Research ArticleArticle

Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4

Potential Contribution to High First-Pass Metabolism

Michael E. Fitzsimmons and Jerry M. Collins
Drug Metabolism and Disposition February 1997, 25 (2) 256-266;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4

Michael E. Fitzsimmons and Jerry M. Collins
Drug Metabolism and Disposition February 1, 1997, 25 (2) 256-266;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement